You and your 'proof' mate. It's an 'opinion', a hunch, a guess. As Oligarch made clear - IMO - "in my opinion". In my opinion (as this is me speaking), I think somebody buying the company following FDA approval is a much better chance than BOT going to sales & distribution themselves. But both Oligarch and I (and others) may be wrong. Either scenario will still make us all good money. Maybe just relax a little concerning others sharing their opinions, or report them to ASIC if that's what does it for you!
BOT - Anything but charting, page-5861
-
- There are more pages in this discussion • 3,773 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.015(4.55%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 35.0¢ | 32.3¢ | $2.184M | 6.494M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 38963 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 34769 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |